Showing results (101-110 of 125) with videos related to
Sort By:
Pageof 13
Leukemia & Lymphoma|July 29, 2016
Autologous Bone Marrow Transplantation Followed by Involved Field Radiotherapy in Patients with Relapsed or Refractory Hodgkin's DiseaseJ A Moormeier, S F Williams, L S Kaminer, et al.Cancer|June 15, 1987
Prophylactic cranial irradiation in adenocarcinoma of the lung. A possible roleR H Jacobs, A Awan, J D Bitran, et al.The Annals of Thoracic Surgery|November 1, 1979
The role of gallium-67 scanning in the clinical staging and preoperative evaluation of patients with carcinoma of the lungT R DeMeester, H M Golomb, P Kirchner, et al.Bone Marrow Transplantation|February 1, 1990
Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approachS F Williams, J D Bitran, J M Richards, et al.Annals of Internal Medicine|September 15, 1992
In-vitro resistance to zidovudine and alpha-interferon in HIV-1 isolates from patients: correlations with treatment duration and responseB R Edlin, M H St Clair, P M Pitha, et al.American Journal of Clinical Oncology|April 1, 1991
Etoposide and mitomycin in the treatment of non-small-cell lung cancer. A phase I-II evaluationD S Ettinger, J D Bitran, R L Comis, et al.British Journal of Cancer|July 19, 2012
Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancerC Nabhan, D Villines, T V Valdez, et al.Cancer Treatment Reports|September 1, 1976
Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinomaJ D Bitran, R K Desser, T R DeMeester, et al.Journal of Surgical Oncology|January 1, 1983
Multimodality therapy of stage III adenocarcinoma of the breastJ D Bitran, R K Desser, D Schifeling, et al.The Cancer Journal From Scientific American|November 1, 1995
A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancerG A Masters, L C Drinkard, P C Hoffman, et al.Pageof 13